Digital Biomarker Market Insights, Global Outlook and Forecast 2022-2028
Digital Biomarker Market Insights, Global Outlook and Forecast 2022-2028
The research report on ‘Digital Biomarker Market’ provides a workplan for stakeholders for the estimated timeframe of -. To elaborate, it offers valid predictions for the size, shares, and growth patterns of this domain over the projected timeline by assessing the past records and present business trends.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.
The latest research study released by Market IntelliX evaluates market size and forecasts of Digital Biomarker in Global, including the following market information:
Global Digital Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Digital Biomarker market was valued at 398.5 million in 2021 and is projected to reach US$ 23440 million by 2028, at a CAGR of 79.0% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Passive Digital Biomarker Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Digital Biomarker include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Apple, Sanofi, GlaxoSmithKline and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Digital Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Digital Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Digital Biomarker Market Segment Percentages, by Type, 2021 (%)
Passive Digital Biomarker
Active Digital Biomarker
Global Digital Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Digital Biomarker Market Segment Percentages, by Application, 2021 (%)
Clinical Disease
Daily Health
Global Digital Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Digital Biomarker Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Digital Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Digital Biomarker revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market Some of the prominent key players covered:
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Apple
Sanofi
GlaxoSmithKline
Bayer
Merck
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Digital Biomarker Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Digital Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Digital Biomarker Overall Market Size
2.1 Global Digital Biomarker Market Size: 2021 VS 2028
2.2 Global Digital Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Digital Biomarker Players in Global Market
3.2 Top Global Digital Biomarker Companies Ranked by Revenue
3.3 Global Digital Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Digital Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Digital Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Digital Biomarker Players in Global Market
3.6.1 List of Global Tier 1 Digital Biomarker Companies
3.6.2 List of Global Tier 2 and Tier 3 Digital Biomarker Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Digital Biomarker Market Size Markets, 2021 & 2028
4.1.2 Passive Digital Biomarker
4.1.3 Active Digital Biomarker
4.2 By Type - Global Digital Biomarker Revenue & Forecasts
4.2.1 By Type - Global Digital Biomarker Revenue, 2017-2022
4.2.2 By Type - Global Digital Biomarker Revenue, 2023-2028
4.2.3 By Type - Global Digital Biomarker Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Digital Biomarker Market Size, 2021 & 2028
5.1.2 Clinical Disease
5.1.3 Daily Health
5.2 By Application - Global Digital Biomarker Revenue & Forecasts
5.2.1 By Application - Global Digital Biomarker Revenue, 2017-2022
5.2.2 By Application - Global Digital Biomarker Revenue, 2023-2028
5.2.3 By Application - Global Digital Biomarker Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Digital Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Digital Biomarker Revenue & Forecasts
6.2.1 By Region - Global Digital Biomarker Revenue, 2017-2022
6.2.2 By Region - Global Digital Biomarker Revenue, 2023-2028
6.2.3 By Region - Global Digital Biomarker Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Digital Biomarker Revenue, 2017-2028
6.3.2 US Digital Biomarker Market Size, 2017-2028
6.3.3 Canada Digital Biomarker Market Size, 2017-2028
6.3.4 Mexico Digital Biomarker Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Digital Biomarker Revenue, 2017-2028
6.4.2 Germany Digital Biomarker Market Size, 2017-2028
6.4.3 France Digital Biomarker Market Size, 2017-2028
6.4.4 U.K. Digital Biomarker Market Size, 2017-2028
6.4.5 Italy Digital Biomarker Market Size, 2017-2028
6.4.6 Russia Digital Biomarker Market Size, 2017-2028
6.4.7 Nordic Countries Digital Biomarker Market Size, 2017-2028
6.4.8 Benelux Digital Biomarker Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Digital Biomarker Revenue, 2017-2028
6.5.2 China Digital Biomarker Market Size, 2017-2028
6.5.3 Japan Digital Biomarker Market Size, 2017-2028
6.5.4 South Korea Digital Biomarker Market Size, 2017-2028
6.5.5 Southeast Asia Digital Biomarker Market Size, 2017-2028
6.5.6 India Digital Biomarker Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Digital Biomarker Revenue, 2017-2028
6.6.2 Brazil Digital Biomarker Market Size, 2017-2028
6.6.3 Argentina Digital Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Digital Biomarker Revenue, 2017-2028
6.7.2 Turkey Digital Biomarker Market Size, 2017-2028
6.7.3 Israel Digital Biomarker Market Size, 2017-2028
6.7.4 Saudi Arabia Digital Biomarker Market Size, 2017-2028
6.7.5 UAE Digital Biomarker Market Size, 2017-2028
7 Players Profiles
7.1 Philips
7.1.1 Philips Corporate Summary
7.1.2 Philips Business Overview
7.1.3 Philips Digital Biomarker Major Product Offerings
7.1.4 Philips Digital Biomarker Revenue in Global Market (2017-2022)
7.1.5 Philips Key News
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Corporate Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Digital Biomarker Major Product Offerings
7.2.4 Johnson & Johnson Digital Biomarker Revenue in Global Market (2017-2022)
7.2.5 Johnson & Johnson Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Digital Biomarker Major Product Offerings
7.3.4 Pfizer Digital Biomarker Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 GE Healthcare
7.4.1 GE Healthcare Corporate Summary
7.4.2 GE Healthcare Business Overview
7.4.3 GE Healthcare Digital Biomarker Major Product Offerings
7.4.4 GE Healthcare Digital Biomarker Revenue in Global Market (2017-2022)
7.4.5 GE Healthcare Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Digital Biomarker Major Product Offerings
7.5.4 Novartis Digital Biomarker Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Apple
7.6.1 Apple Corporate Summary
7.6.2 Apple Business Overview
7.6.3 Apple Digital Biomarker Major Product Offerings
7.6.4 Apple Digital Biomarker Revenue in Global Market (2017-2022)
7.6.5 Apple Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Digital Biomarker Major Product Offerings
7.7.4 Sanofi Digital Biomarker Revenue in Global Market (2017-2022)
7.7.5 Sanofi Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Digital Biomarker Major Product Offerings
7.8.4 GlaxoSmithKline Digital Biomarker Revenue in Global Market (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Digital Biomarker Major Product Offerings
7.9.4 Bayer Digital Biomarker Revenue in Global Market (2017-2022)
7.9.5 Bayer Key News
7.10 Merck
7.10.1 Merck Corporate Summary
7.10.2 Merck Business Overview
7.10.3 Merck Digital Biomarker Major Product Offerings
7.10.4 Merck Digital Biomarker Revenue in Global Market (2017-2022)
7.10.5 Merck Key News
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Corporate Summary
7.11.2 Abbott Laboratories Business Overview
7.11.3 Abbott Laboratories Digital Biomarker Major Product Offerings
7.11.4 Abbott Laboratories Digital Biomarker Revenue in Global Market (2017-2022)
7.11.5 Abbott Laboratories Key News
7.12 Asahi Kasei
7.12.1 Asahi Kasei Corporate Summary
7.12.2 Asahi Kasei Business Overview
7.12.3 Asahi Kasei Digital Biomarker Major Product Offerings
7.12.4 Asahi Kasei Digital Biomarker Revenue in Global Market (2017-2022)
7.12.5 Asahi Kasei Key News
7.13 Biogen
7.13.1 Biogen Corporate Summary
7.13.2 Biogen Business Overview
7.13.3 Biogen Digital Biomarker Major Product Offerings
7.13.4 Biogen Digital Biomarker Revenue in Global Market (2017-2022)
7.13.5 Biogen Key News
7.14 Koneksa Health
7.14.1 Koneksa Health Corporate Summary
7.14.2 Koneksa Health Business Overview
7.14.3 Koneksa Health Digital Biomarker Major Product Offerings
7.14.4 Koneksa Health Digital Biomarker Revenue in Global Market (2017-2022)
7.14.5 Koneksa Health Key News
7.15 Roche
7.15.1 Roche Corporate Summary
7.15.2 Roche Business Overview
7.15.3 Roche Digital Biomarker Major Product Offerings
7.15.4 Roche Digital Biomarker Revenue in Global Market (2017-2022)
7.15.5 Roche Key News
7.16 Huma Therapeutics
7.16.1 Huma Therapeutics Corporate Summary
7.16.2 Huma Therapeutics Business Overview
7.16.3 Huma Therapeutics Digital Biomarker Major Product Offerings
7.16.4 Huma Therapeutics Digital Biomarker Revenue in Global Market (2017-2022)
7.16.5 Huma Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Digital Biomarker Market Opportunities & Trends in Global Market
Table 2. Digital Biomarker Market Drivers in Global Market
Table 3. Digital Biomarker Market Restraints in Global Market
Table 4. Key Players of Digital Biomarker in Global Market
Table 5. Top Digital Biomarker Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Digital Biomarker Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Digital Biomarker Revenue Share by Companies, 2017-2022
Table 8. Global Companies Digital Biomarker Product Type
Table 9. List of Global Tier 1 Digital Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Digital Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Digital Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Digital Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Digital Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Digital Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Digital Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Digital Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Digital Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Digital Biomarker Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Digital Biomarker Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Digital Biomarker Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Digital Biomarker Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Digital Biomarker Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Digital Biomarker Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Digital Biomarker Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Digital Biomarker Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Digital Biomarker Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Digital Biomarker Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Digital Biomarker Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Digital Biomarker Revenue, (US$, Mn), 2023-2028
Table 30. Philips Corporate Summary
Table 31. Philips Digital Biomarker Product Offerings
Table 32. Philips Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Digital Biomarker Product Offerings
Table 35. Johnson & Johnson Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Digital Biomarker Product Offerings
Table 38. Pfizer Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 39. GE Healthcare Corporate Summary
Table 40. GE Healthcare Digital Biomarker Product Offerings
Table 41. GE Healthcare Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Digital Biomarker Product Offerings
Table 44. Novartis Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 45. Apple Corporate Summary
Table 46. Apple Digital Biomarker Product Offerings
Table 47. Apple Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Digital Biomarker Product Offerings
Table 50. Sanofi Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline Corporate Summary
Table 52. GlaxoSmithKline Digital Biomarker Product Offerings
Table 53. GlaxoSmithKline Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Digital Biomarker Product Offerings
Table 56. Bayer Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Digital Biomarker Product Offerings
Table 59. Merck Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 60. Abbott Laboratories Corporate Summary
Table 61. Abbott Laboratories Digital Biomarker Product Offerings
Table 62. Abbott Laboratories Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 63. Asahi Kasei Corporate Summary
Table 64. Asahi Kasei Digital Biomarker Product Offerings
Table 65. Asahi Kasei Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 66. Biogen Corporate Summary
Table 67. Biogen Digital Biomarker Product Offerings
Table 68. Biogen Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 69. Koneksa Health Corporate Summary
Table 70. Koneksa Health Digital Biomarker Product Offerings
Table 71. Koneksa Health Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 72. Roche Corporate Summary
Table 73. Roche Digital Biomarker Product Offerings
Table 74. Roche Digital Biomarker Revenue (US$, Mn), (2017-2022)
Table 75. Huma Therapeutics Corporate Summary
Table 76. Huma Therapeutics Digital Biomarker Product Offerings
Table 77. Huma Therapeutics Digital Biomarker Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Digital Biomarker Segment by Type in 2021
Figure 2. Digital Biomarker Segment by Application in 2021
Figure 3. Global Digital Biomarker Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Digital Biomarker Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Digital Biomarker Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Digital Biomarker Revenue in 2021
Figure 8. By Type - Global Digital Biomarker Revenue Market Share, 2017-2028
Figure 9. By Application - Global Digital Biomarker Revenue Market Share, 2017-2028
Figure 10. By Region - Global Digital Biomarker Revenue Market Share, 2017-2028
Figure 11. By Country - North America Digital Biomarker Revenue Market Share, 2017-2028
Figure 12. US Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Digital Biomarker Revenue Market Share, 2017-2028
Figure 16. Germany Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 17. France Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Digital Biomarker Revenue Market Share, 2017-2028
Figure 24. China Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 28. India Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Digital Biomarker Revenue Market Share, 2017-2028
Figure 30. Brazil Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Digital Biomarker Revenue Market Share, 2017-2028
Figure 33. Turkey Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Digital Biomarker Revenue, (US$, Mn), 2017-2028
Figure 37. Philips Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GE Healthcare Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Apple Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Abbott Laboratories Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Asahi Kasei Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Biogen Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Koneksa Health Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Roche Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Huma Therapeutics Digital Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Research Methodology:
Digital Biomarker Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|